In this review:
Proteasome inhibitor-based therapy for reduction of HLA sensitization
Peripheral neuropathy with bortezomib-based therapy
Alemtuzumab vs thymoglobulin and basiliximab in renal transplantation
Terminal complement inhibition decreases early AHR
Everolimus p
Please login below to download this issue (PDF)